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Abstract
Anti-NeuN (Neuronal Nuclei) is a monoclonal antibody used extensively to specifically detect post-mitotic neurons. Anti-
NeuN reactivity is predominantly nuclear; by western it detects multiple bands ranging in molecular weight from 45 kDa to
.75 kDa. Expression screening putatively identified R3hdm2 as NeuN; however immunoprecipitation and mass
spectrometry of the two major NeuN species at 45–50 kDa identified both as the RNA binding protein Rbfox3 (a member
of the Fox family of alternative splicing factors), confirming and extending the identification of the 45 kDa band as Rbfox3
by Kim et al. Mapping of the anti-NeuN reactive epitopes in both R3hdm2 and Rbfox3 reveals a common proline- and
glutamine-rich domain that lies at the N-terminus of the Rbfox3 protein. Our data suggests that alternative splicing of the
Rbfox3 pre-mRNA itself leads to the production of four protein isoforms that migrate in the 45–50 kDa range, and that one
of these splicing choices regulates Rbfox3/NeuN sub-cellular steady-state distribution, through the addition or removal of a
short C-terminal extension containing the second half of a bipartite hydrophobic proline-tyrosine nuclear localization signal.
Rbfox3 regulates alternative splicing of the Rbfox2 pre-mRNA, producing a message encoding a dominant negative form of
the Rbfox2 protein. We show here that nuclear Rbfox3 isoforms can also enhance the inclusion of cryptic exons in the
Rbfox2 mRNA, resulting in nonsense-mediated decay of the message, thereby contributing to the negative regulation of
Rbfox2 by Rbfox3 through a novel mechanism.
Citation: Dredge BK, Jensen KB (2011) NeuN/Rbfox3 Nuclear and Cytoplasmic Isoforms Differentially Regulate Alternative Splicing and Nonsense-Mediated Decay
of Rbfox2. PLoS ONE 6(6): e21585. doi:10.1371/journal.pone.0021585
Editor: Juan Valcarcel, Centre de Regulacio ´ Geno `mica, Spain
Received December 5, 2010; Accepted June 6, 2011; Published June 29, 2011
Copyright:  2011 Dredge, Jensen. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This project was funded by the ARC Special Research Centre for the Molecular Genetics of Development and ARC Discovery Project Grant DP0559550
arc.gov.au. BKD was funded in part as an APD on ARC Discovery Project Grant DP0559550. No additional external funding was received for this study. The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: kate.dredge@adelaide.edu.au
Introduction
NeuN (Neuronal Nuclei) is a protein ‘marker’ detected
exclusively in post-mitotic neurons that was initially identified
through an immunologic screen to produce neuron-specific
antibodies. The result of this screen, in which mice immunized
with mouse brain nuclei extracts were used to derive a panel of
monoclonal antibodies (mAbs), was mAb A60 (anti-NeuN), which
recognizes at least two major protein species migrating at
approximately 45–50 kDa, by western of brain extracts [1,2]. In
addition to the 45–50 kDa NeuN doublet, some cell lysate
preparations show additional reactive bands at ,66 kDa, and
between ,70–90 kDa by western. Immunohistochemically, NeuN
is detected only in mature neurons and is absent from neural
progenitors, glia, oligodendrocytes and astrocytes [2]. In general,
NeuN reactivity is predominantly nuclear, although it can also be
detected in the cytoplasm of many neuronal cell types [2,3]. It has
been hypothesized that NeuN may be required for the
maintenance of the post-mitotic state, or during the process of
axonogenesis [4], but these questions have been impossible to
address without the molecular characterization of NeuN.
Despite the widespread use of the anti-NeuN mAb, the identity
of the NeuN protein remained elusive for 17 years. As a result,
almost nothing was known about the function of NeuN protein
beyond a demonstrated ability to bind DNA in vitro [2]. Kim et al.
[5] and work presented here identify NeuN as Rbfox3. The Fox
(feminizing on X) proteins are a highly conserved family of tissue-
specific splicing regulators that each harbor a single RNA-
recognition motif (RRM)-type RNA binding domain. Rbfox1
(A2bp1) is expressed in neurons, skeletal muscle and heart [6–9].
Rbfox2 (Rbm9) is expressed in ovary, whole embryo, and human
embryonic cell lines in addition to neurons and muscle [6,10].
Rbfox3 (Hrnbp3, D11Bwg0517e) message is detected exclusively
in post-mitotic regions of embryonic mouse brain [11]. Fox
proteins have been shown to regulate a large number of brain and
muscle-specific splice choices via binding to the hexanucleotide
UGCAUG, including: exon EIIIB of fibronectin; exon N1 of c-src;
and calcitonin/CGRP [6,8,12].
All Fox family members are subject to alternative splicing; we
show here that the major NeuN products seen by Western are
created by two separate alternative splicing events that create
Rbfox3 protein variants with either nuclear or cytoplasmic steady-
state distribution. We have tested three individual Rbfox3 proteins
in alternative splicing assays and find that all of these Rbfox3
protein isoforms repress inclusion of the alternative RRM exon,
exon 6, of Rbfox2, giving rise to a variant of Rbfox2 without a
functional RRM. An equivalent alternatively spliced exon is also
found in mammalian Rbfox1 and Rbfox3, as well as in the
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that these FoxDRRM isoforms encode proteins that can act as
dominant negative splicing factors [13]. Regulation of this splice
choice represents one mechanism for modulation of Fox protein
function in cells expressing multiple Fox family members [13].
A number of splicing factors, including SC35 and polypyr-
imidine tract binding protein (PTB/Ptbp1), have been shown to
autoregulate their expression by regulating alternative splicing of
their own pre-mRNA to enhance the production of mRNA
isoforms that are subject to nonsense-mediated decay (NMD)
[14,15]. NMD is a surveillance pathway that is triggered in
mammalian cells when an mRNA contains a nonsense codon
more that 50–55 nucleotides upstream of an exon-exon junction
[16]. Our alternative splicing assays also reveal evidence of a
second, novel mechanism of Fox family cross-regulation through
alternative splicing associated nonsense-mediated decay (NMD).
Results
We initially sought to identify NeuN using a lambda phage
library-screening approach. We used anti-NeuN to screen a cDNA
expression library derived from P0 mouse spinal cord poly(A)
+
RNA and isolated four independent, overlapping clones encoding
the poorly characterized protein R3hdm2 (KIAA1002). This
protein contains only one known protein motif, an R3H domain,
which has been shown to bind single-stranded nucleic acid [17].
Deletion mapping of the smallest positive clone was used to
narrow the anti-NeuN antibody-binding site (ABS) to a 46 amino
acid domain necessary and sufficient for recognition of GST-
R3hdm2 fusions by western with anti-NeuN (Figure 1A).
While our data demonstrate that anti-NeuN is able to
recognize R3hdm2 in vitro, the full-length clones isolated from
our screen encode proteins of ,110 kDa, clearly much larger
than the classic 45–50 kDa NeuN doublet seen by western.
Furthermore, northern analysis (Figure 1B) shows that R3hdm2
message, while enriched in mouse brain, spinal cord and testes, is
also present in lower levels in other tissues. Thus, while the
R3hdm2 mRNA is most abundant in brain, tissue regulation of
the message cannot by itself account for the exquisite neuronal
specificity of anti-NeuN protein recognition. Given the discrep-
ancies in the molecular weight and expression properties of
R3hdm2 and NeuN, we employed an alternative approach in an
effort to unambiguously identify NeuN.
Identification of the NeuN doublet as Rbfox3 by
immunoprecipitation and mass spectrometry
To directly identify the major 45–50 kDa NeuN doublet, we
immunoprecipited (IPed) NeuN with anti-NeuN mAb, separated
the eluate by SDS-PAGE and subjected excised protein bands to
mass spectrometry (MS). To avoid interference of IgG heavy-
chain, which runs at a similar molecular weight to NeuN on
reducing SDS-PAGE, we crosslinked the anti-NeuN antibody to
protein-A sepharose beads, and ran non-reducing gels. We saw
antibody-dependent enrichment of bands corresponding in size to
the NeuN doublet by silver-stain and western of IPed fractions
(Figure 2A & 2B). While a number of other proteins were also
specifically IPed under these conditions, since the majority of these
bands do not appear to be recognized by anti-NeuN western, they
may represent NeuN-interacting proteins, and were not analyzed
further. However, there were a series of bands ,100–110 kDa in
size that were revealed by western as specifically IPed by anti-
NeuN (Figure 2B) and these are consistent in size with isoforms of
R3hdm2. Conversely, several species between 60 and 80 kDa that
are clearly detected by western were neither depleted from the
extract nor present in the IPed fraction. The experiment shown in
Figures 2A and 2B was performed using a crude nuclear
preparation that was not further purified to remove cellular
membranes; based on the work of Kim et al. [5], we suspect that
the largest of these (if not several of them) is likely to be synapsin 1,
a synaptic vesicle-associated protein which they showed can be
detected using anti-NeuN by western.
Figure 1. R3hdm2 reacts with anti-NeuN antibody. A. The depicted GST-fusion proteins were expressed in bacteria and cell lysates analyzed by
western. The upper western panel (anti-GST) confirms that proteins of the expected sizes were expressed after IPTG induction. ABS=antibody
binding site; FL=full-length R3hdm2; the R3H domain is also shown. The membrane was then stripped and reprobed with anti-NeuN antibody (lower
panel), which indicates that the defined ABS region is both necessary and sufficient for anti-NeuN recognition of R3Hdm2. B. Northern of poly(A)
+
RNA isolated from adult mouse tissues and probed for R3hdm2. The level of R3hdm2 expression was normalised to b-actin (lower panel) for each
tissue and calculated relative to the expression level in thymus.
doi:10.1371/journal.pone.0021585.g001
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were cut from the silver-stained gel and subsequently digested with
chymotrypsin, followed by tandem MS analysis of the resulting
peptides. The choice to use chymotrypsin rather than the more
routinely used trypsin was made because our lambda-screen
candidate R3hdm2 contains a striking paucity of predicted tryptic
cleavage sites, particularly surrounding the mapped antibody
binding site (ABS). We reasoned that if NeuN was indeed
R3hdm2, or a portion thereof, a tryptic digest could fail to
produce peptides suitable for an identification to be made using
MS. While the MS analysis was successful with chymotrypsin, no
peptides corresponding to R3hdm2 were detected. Instead, six
Figure 2. Immunoprecipitation and mass spectrometry identify Rbfox3 as the target of anti-NeuN. A. Silver stain of proteins
immunoprecipitated from P20 mouse brain crude nuclear extract using anti-NeuN, and separated by non-reducing SDS-PAGE. No antibody, ands
mouse IgG were used as IP controls; the no lysate sample was used to check the integrity of anti-NeuN cross-linking (covalent coupling) to the beads.
Arrows point to the bands analyzed by mass spectrometry. B. Western confirms the specificity of the anti-NeuN immunoprecipitation. The ‘‘classic’’
NeuN doublet species below 50 kDa were efficiently immunoprecipitated, and depleted from the supernatant (supe), while the upper
immunoreactive bands were not. C. Alignment of the mouse Fox protein family. Accession numbers of the sequences shown are; Rbfox1 (Fox-1,
A2bp1, Hrnbp1) NP_067452, Rbfox2 (Fox-2, Rbm9, Fxh) NP_001104299, Rbfox3 (Fox-3, Hrnbp3) NP_001034256. Amino acids that differ in sequence
from Rbfox3 are shown in grey. Lower case italics denote regions of Rbfox3 that may be absent due to alternative splicing. The RRM domain (as
defined by UniProt) is contained within parentheses. Black lines above the sequence mark peptides identified by MS after in-gel digestion with
chymotrypsin (c) or trypsin (t). Boxes surround Rbfox3 residues that match the hPY-NLS consensus. D. Alignment of the anti-NeuN ABS from R3hdm2
with the N-terminus of Rbfox3 and the predicted antibody-binding region of Syn1 from Kim et al. [5]. Amino acids identical to those in Rbfox3 are
shaded grey, boxes outline amino acids that are identical across all three proteins.
doi:10.1371/journal.pone.0021585.g002
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c6, in Figure 2C), a recently characterized member of the Fox
family of alternative splicing regulators. Of these, three peptides
(c1–c3) were derived from portions of the protein that are identical
in the 3 members of the Fox protein family. The remaining three
peptides (c4–c6) correspond only to Rbfox3 and thus allowed for
unequivocal identification of the protein. Peptides c1 and c2 were
seen in the analysis of the lower band only, whereas peptides c3–c6
were detected after digest of both the upper and lower bands of the
NeuN doublet. Thus we provide direct evidence that the upper,
50 kDa band of the NeuN doublet is Rbfox3 in addition to
independently confirming the mass–spectrometric identification of
the 45 kDa band performed by Kim et al. [5].
A further experiment using purified mouse brain nuclear extract
and in-gel tryptic digest of the lower NeuN band revealed four
peptides derived from Rbfox3. Again, two of these (t3 and t4) are
unique to Rbfox3, while the remaining two are common to the
Fox family. The Rbfox3 pre-mRNA is alternatively spliced in a
number of regions resulting in changes to the encoded protein (see
Figure 3C and [13]). From our MS data, we were able to
determine that both of the NeuN doublet bands are indeed Rbfox3,
and both include a cassette exon, exon 8, which encodes the C-
terminal half of the RRM domain. Thus, while we were able to
unambiguously identify both of the immunoprecipitated bands as
Rbfox3 with full-length RRMs, we found no other peptides that
corresponded to alternatively spliced regions. As a consequence,
the MS data did not provide an explanation for the ,5 kDa
difference in molecular weight between the upper and lower NeuN
bands.
The anti-NeuN epitope resides at the extreme N-terminus
of Rbfox3
We next aligned our mapped anti-NeuN epitope from R3hdm2
with the Rbfox3 protein sequence in order to predict the likely
anti-NeuN epitope in Rbfox3. Figure 2D shows that a portion of
the 46 amino acid R3hdm2 ABS is identical in 8 of 15 amino acids
to the N-terminal region of Rbfox3. Of these, 5 residues are also
identical to the region of synapsin 1a predicted to be a weak
epitope for anti-NeuN by Kim et al. [5]. To directly test whether
anti-NeuN recognizes Rbfox3 via this region, we created the
deletion construct Fox3D-myc, which lacks Rbfox3 amino acids 5–
20 (replaced with the sequence GSAP), and the construct F20-
myc, which harbors Rbfox3 amino acids 2–20 immediately C-
terminal of glutathione S-transferase (GST) (Figure 3A). We
transfected these constructs into 293T cells and compared their
detection with anti-NeuN by western to a full-length Rbfox3
(Fox3-myc), the construct R46-myc (a GST-R3hdm2 ABS fusion)
and GST alone. All of the tested constructs contain a myc-tag to
allow detection of the proteins by western using an anti-myc
antibody. Figure 3B shows that the N-terminal 21 amino acids of
Rbfox3 are necessary and sufficient for recognition of the protein
by anti-NeuN. Taking into account the relative amounts of protein
seen with anti-myc staining, anti-NeuN appears to recognize full-
length Fox3-myc slightly better than F20-myc, and F20-myc
slightly better than R46-myc.
Alternative splicing of Rbfox3 pre-mRNA can account for
the pattern of NeuN bands seen by western
The Rbfox3 mRNA exists as multiple splice variants (see
Figure 3C and [13]). We cloned the coding sequence of the three
most common mouse Rbfox3 mRNA variants (variants 1–3 in the
NCBI database) downstream of a flag-tag sequence and expressed
them in HeLa cells. Variant 1 includes a 47 amino acid protein-
coding domain derived from an extended exon 12, and a 14
amino-acid C-terminal protein coding domain derived from exon
15, both of which are created by the use of alternative 39 splice
sites in the respective upstream introns. Variant 2 lacks the
additional exon 12 protein-coding sequence found in variant 1,
but contains the same C-terminal protein-coding sequence as
variant 1. Variant 3 lacks both of these additional protein-coding
domains. The calculated molecular weights of these Rbfox3
Figure 3. The anti-NeuN epitope of Rbfox3 maps to the
extreme N-terminus of the protein. A,B. The proteins depicted in
A were expressed in 293T cells and analyzed by western with anti-myc-
tag (left panel), or anti-NeuN antibodies on duplicate blots. Anti-NeuN
recognises both F20 and R46, and amino acids 5–20 (deleted in Fox3D-
myc) are necessary for recognition of full-length Rbfox3 by anti-NeuN.
C. Three Rbfox3 splice variants were expressed in HeLa cells and
compared to NeuN from mouse brain by western with anti-NeuN.
Variant 1 (v1) corresponds to NP_001034256, v2 to NP_001034257, and
v3 to NP_001020102. Exon numbers are as described in [13]. D. RT-PCR
of total RNA from P19 cells prior to neuronal induction (lanes 1), P19
cells 7 days after neuronal induction with RA (lanes 2), and P10 mouse
brain (lanes 3). For Rbfox3, 3 reverse primers were used to assess
mRNAs that encode the short C-terminus (or -IGTM protein isoforms,
15A-R), the longer, -FTPY isoforms (15-R), or all mRNAs (14-R). A
common forward primer to exon 7 (7-F) was used for all. Gapdh was
used as a loading control.
doi:10.1371/journal.pone.0021585.g003
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35.5 kDa; variant 3, 34.1 kDa.
We had previously noticed that the Fox3-myc protein migrated
on SDS-PAGE gels at a molecular weight slightly greater than its
calculated molecular weight. When we analyzed the Rbfox3
protein variants by SDS-PAGE and detection with anti-NeuN,
flag-Fox3v1 ran at a slightly greater molecular weight than the
upper NeuN band from mouse brain, while variants 2 and 3 ran at
similar but not identical positions in the gel, both at a slightly
greater molecular weight than the lower NeuN band (Figure 3C).
If one accounts for both the general Rbfox3 protein migration
discrepancy and the added molecular weight of the flag-tag, the gel
migration behavior of the Rbfox3 protein variants strongly
suggests that the 45 and 50 kDa NeuN bands represent ‘2exon
12’ and ‘+exon 12’ variants respectively. Furthermore, close
inspection of anti-NeuN westerns reveals that the antibody actually
recognizes a ‘‘doublet of doublets’’ ([1,2] and our data not shown),
where both the 45 and 50 kDa ‘bands’ are actually composed of
two individual protein species differing very slightly in molecular
weight. This data suggests that both the 45 and 50 kDa ‘bands’ are
composed of a mixture of Rbfox3 proteins alternatively spliced at
exon 15. Thus, alternative splicing of the Rbfox3 message in exon
12 and exon 15 produces four protein isoforms that can account
for the 45–50 kDa doublet of doublets that are detected with anti-
NeuN. Two other regions of the Rbfox3 coding sequence can also
be alternatively spliced. Exon 6 contains two alternative 39 splice
sites just 3 nt apart, creating proteins +/2 a single glutamine
residue, which were not analyzed in this study. Exon 8, which
encodes 31 amino acids (3.4 kDa) of the RRM domain, is a
cassette exon that can be included or skipped; the MS data
demonstrated that both the 45 and 50 kDa NeuN/Rbfox3 bands
include exon 8, so alternative splicing of this exon cannot account
for the migration difference between these two ‘bands.’
It has been well documented that the NeuN protein is expressed
in P19 embryonic carcinoma cells after neural induction with
retinoic acid, but cannot be detected in uninduced P19 cells [2,5].
We examined Rbfox3 mRNA expression in these two P19
differentiation states by RT-PCR, along with mouse brain tissue
as a control. To carry out this analysis, we used a forward primer
to exon 7 (7F) and three reverse primers, 15AR, 15R and 14R (see
the Rbfox3 pre-mRNA diagram in Figure 3D): the primer to exon
15A (15AR) amplified mRNA variant 3 and other isoforms lacking
the 14 amino acid C-terminal peptide extension; the primer to
exon 15 (15R) amplified message variants 1 and 2 and any other
isoforms encoding the C-terminal extension; finally, the primer to
exon 14 (14R) was used as a control to amplify all Rbfox3 mRNA
isoforms, but gives no information about splicing of the final intron
and thus the C-terminal composition of the protein products. As
shown in Figure 3D, very little Rbfox3 message was detected in
uninduced P19 cells (lanes 1), and the modest amount of product
that was amplified corresponds to Rbfox3 protein with the shorter
C-terminus. There was also a trace amount of product
corresponding to messages lacking exon 8 in these cells. As stated
above, skipping of exon 8 leads to a 31 amino acid deletion within
the RRM domain. EST evidence supports the presence of this
isoform in mouse retina, however, we have no evidence that
Rbfox3DRRM protein, which should retain reactivity with anti-
NeuN, is expressed in detectable levels in any tissues or cell lines
tested so far.
Induction of P19 cells with retinoic-acid results in a large
increase in the abundance of all Rbfox3 message variants as
assayed by RT-PCR (lanes 2). The complement of transcripts seen
in induced P19 cells is very similar to that seen in P10 mouse brain
(lanes 3) in which the majority of transcripts lack exon 12, and
both exon 15 variants are present. Taken together with our MS
and western data, the RT-PCR studies support our finding that
alternative splicing of exons 12 and 15 is the basis of the doublet of
doublets observed by western analysis of mouse brain and induced
P19 cells with anti-NeuN.
Rbfox3 sub-cellular localization is regulated by
alternative splicing
NeuN is reported to be predominantly nuclear, although
cytoplasmic staining has been observed in subsets of neurons
[2,3]. To investigate their sub-cellular localization, we transfected
vectors encoding the Rbfox3 variants 1–3 into HeLa cells and
analyzed them by immunofluorescence with anti-NeuN. We
initially used constructs harboring C-terminal myc-tags and found
that all three Rbfox3 protein variants localized to the cytoplasm, in
contrast to the expected nuclear localization (Figure 4).
Interestingly, the Rbfox1 pre-mRNA can also be alternatively
spliced to produce Rbfox1 protein variants with unique C-termini;
Rbfox1 isoforms that end in the sequence –FAPY are predom-
inantly nuclear at steady-state, whereas isoforms ending in –
TALVP are predominantly cytoplasmic [18]. Recently, it was
noted that the –FAPY C-termini variants of Rbfox1 and 22
match the two-part consensus hydrophobic proline-tyrosine
nuclear localization sequence (hPY-NLS); namely wG/A/
SwwX(11–13)PY and R/H/KX(2–5)PY where w represents a
hydrophobic side chain [19,20]. The C-terminal extension
variants of Rbfox3 also satisfy this two-part NLS signal
(highlighted in Figure 2C); Rbfox3 variants without the C-
terminal extension harbor only the first half of the bipartite NLS
signal. Proteins harboring an hPY-NLS motif interact with a
negatively charged binding interface on the nuclear import factor
Karyopherin ß 2 (Kap ß 2) [19]. Therefore, we reasoned that
adding an acidic myc-tag immediately adjacent to the hPY-NLS in
Rbfox3 may weaken or even abolish its interaction with Kap ß 2,
resulting in altered steady-state sub-cellular distribution of the
proteins.
We repeated our experiment with constructs containing N-
terminal flag-tags (Figure 4). In this instance, Fox3v1 was
predominantly nuclear, while Fox3v2 appeared to be exclusively
nuclear and Fox3v3 appeared to be predominantly cytoplasmic;
Fox3v2 and Fox3v3 differ only by the presence or absence of the 14
amino-acid C-terminal extension respectively, yet show starkly
different steady-state sub-cellular distribution.
All 3 Rbfox3 variants can regulate alternative splicing
The Fox family of RNA binding proteins are known to regulate
alternative splicing of a number of pre-mRNAs [6,8,10,12,21].
Since pre-mRNA splicing occurs in the nucleus, we asked whether
both nuclear and cytoplasmic forms of Rbfox3 could regulate
alternative splicing. N2A and 293T cells were transiently
transfected with N-terminal flag-tagged Rbfox3 constructs and
harvested 24 hours post-transfection. The splicing of endogenous
mRNAs was then assayed by RT-PCR using a FAM-labeled 39
primer. Rbfox3v1 protein has previously been shown to inhibit the
usage of exon 6 in Rbfox2 pre-mRNA (Rbfox3v2 and v3 have not
been tested) [13]. Skipping of this exon creates an in-frame
deletion in the RRM domain and results in production of a
dominant negative isoform of Rbfox2 [13]. Consistent with this
known role of Rbfox3v1, our data in Figure 5A shows that the
addition of exogenous Rbfox3 results in skipping of exon 6 of
Rbfox2. This effect is more pronounced in 293T cells, probably
due to the higher transfection efficiency achieved in these cells
(,82% for 293T versus ,50% for N2A cells). Surprisingly, the
amount of exon 6 skipping is similar regardless of whether cells are
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nuclear Rbfox3 variants v1 and v2; exon 6-containing mRNA was
reduced from 92% of total Rbfox2 message for the empty vector
control in 293T cells, to 47%, 48% and 39% for Fox3v1, v2 and
v3 respectively (Figure 5A,C). This observation was confirmed by
titration of the amount of plasmid transfected and subsequent
quantification of Rbfox3 protein expression by fluorescent
western. At similar expression levels of each of the Rbfox3
variants, the degree of Rbfox2 splicing regulation/alteration from
baseline is comparable, as measured by the decrease in the steady-
state amount of the productive +e6 pre-mRNA isoform (Figure
S1). This robust splicing regulatory activity implies that either
cytoplasmic Fox3v3 can influence the splicing of Rbfox2 pre-
mRNA indirectly or, more likely, that Fox3v3 can shuttle between
the nucleus and cytoplasm and regulate splicing directly.
Although all three Rbfox3 variants tested robustly repressed
inclusion of Rbfox2 exon 6 in 293T cells, the nature of the
alternative products detected is different (Figures 5 and S1).
Fox3v1 and v2 transfected 293T cells harbored significant
amounts of a third mRNA species that includes a cryptic exon
derived from intron 6 of the Rbfox2 pre-mRNA that we have
called exon 6*. Exon 6* is 74 nt in human 293T cells, and 71 nt in
mouse N2A cells, but in both cases introduces a premature stop
codon which would result production of a truncated protein or,
more likely, target the mRNA for NMD (see below). This exon 6*-
containing mRNA accounts for 20% and 25% of total Rbfox2
mRNA when Fox3v1 and v2 are transfected, respectively,
compared to only 5% for Fox3v3 and 2% for pcDNA3. In
contrast, in cells transfected with the cytoplasmically localized
Fox3v3, 56% of Rbfox2 mRNA excludes both exon 6 and exon
6*, compared with 33% for Fox3v1, 27% for Fox3v2 and 6% for
pcDNA3. Rbfox3 transfected N2A cells show a similar trend,
although the magnitude of the changes is lower.
Interestingly, expression of the predominantly cytoplasmic C-
terminal myc-tagged Fox3 variants in 293T cells also resulted in
changes to Rbfox2 pre-mRNA splicing which most closely
resembled those induced by Fox3v3 (Figure S1). By again
comparing samples with similar Rbfox3 protein expression levels,
we observed that the cytoplasmic, myc-tagged Fox3v1 and v2
proteins were as effective in causing skipping of Rbfox2 exon 6
(reduction to approximately 50% of total message) as their flag-
tagged nuclear counterparts. However, unlike the flag-tagged
variants, the amount of +e6* containing-mRNA detected
accounted for less than 10% of the total Rbfox2 message. Again,
we are unable to conclude whether these myc-tagged variants are
affecting Rbfox2 splicing indirectly in the cytoplasm, or instead
retain the ability to be imported to the nucleus.
We also analyzed splicing of additional reported targets of Fox
protein-dependent splicing regulation, namely c-src and CaV1.2
[6,22]. Upon overexpression in N2A cells, Rbfox1 and Rbfox2
have been shown to enhance the inclusion of a neuron-specific
exon N1 in endogenous c-src message, and minigene assays have
revealed that this splicing activation is dependent on Fox protein
binding to UGCAUG elements downstream of exon N1 [6].
Rbfox3 has not been assayed as regulator of c-src alternative
splicing. Interestingly, we did not detect a change in N1 exon
inclusion with any of the Rbfox3 protein variants when
overexpressed in N2A cells (293T cells do not exhibit any
measurable inclusion of the N1 exon with or without the Rbfox3
proteins). Thus, either c-src N1 splicing cannot be regulated by
Rbfox3, or the levels of Fox proteins required to regulated c-src
splicing are much higher than those required to regulate Rbfox2
exon 6 splicing, and were insufficient in our experiments.
Overexpression of Rbfox1 and Rbfox2 has been shown to
repress exon 9* but enhance exon 33 splicing in the CaV1.2
voltage-gated calcium channel pre-mRNA [22], and Rbfox3 has
Figure 4. The C-terminus of Rbfox3 specifies sub-cellular location. Rbfox3 variants 1, 2 and 3 harboring C-terminal myc-tags (A), or
N-terminal flag-tags (B) were expressed in HeLa cells and stained with anti-NeuN and DAPI. All C-terminally tagged proteins displayed predominantly
cytoplasmic localization, whereas N-terminally tagged Fox3v1 and v2 displayed the expected nuclear localization. Scale bars indicate 50 mm.
doi:10.1371/journal.pone.0021585.g004
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context) [13]. Again, we did not see any alterations in splicing of
CaV1.2 exons 9* or 33 in our Rbfox3 overexpression experiments.
Thus we can conclude that the c-src and CaV1.2 pre-mRNAs are
either weaker targets of Rbfox3-dependent splicing regulation
than the Rbfox2 pre-mRNA in these cell lines, or not targets at all.
Rbfox3 promotes nonsense-mediated decay of Rbfox2
transcripts
Since NMD requires active translation, treatment of mamma-
lian cells with pharmacological inhibitors of translation results in
the accumulation of transcripts normally targeted for NMD [23].
To further investigate whether Rbfox2 mRNAs including exon 6*
are subject to NMD we treated N2A cells transiently transfected
with our flag-tagged Rbfox3 constructs with the translation
inhibitor emetine. We assayed skipping of exon 10 of polypyr-
imidine tract binding protein 2 (Ptbp2) by RT-PCR as a positive
control for emetine treatment (Figure 6) since the isoform lacking
exon 10 harbors a premature termination codon, and has been
shown to accumulate when the NMD pathway is blocked [24,25].
Emetine treatment alone had no effect on the relative levels of the
different exon 6 Rbfox2 mRNA isoforms present in cells
transfected with the empty pcDNA vector. However, N2A cells
transfected with exogenous Rbfox3 showed a marked increase in
accumulation of Rbfox2 mRNA containing exon 6* after
treatment with emetine. Furthermore, this treatment revealed
yet another mRNA species, this time containing a cryptic exon
derived from Rbfox2 intron 5 that we have called exon 5*
(Figure 6). Emetine treatment increases the abundance of
transcripts containing either of these cryptic exons from 5% to
17% in cells expressing Fox3v1, from 6% to 17% for Fox3v2, and
from 4% to 8% for Fox3v3. Inclusion of either exon 6* or exon 5*
(which is 41 nt) alters the reading frame of the mRNA introducing
two premature termination codons in the downstream exon, exon
7, as depicted in Figure 6D. Thus our data shows that Rbfox3
regulates alternative splicing of Rbfox2 to enhance the production
of mRNA species that are targeted for NMD. This is likely to be a
phylogenetically conserved mechanism of Fox family autoregula-
tion since both of these cryptic exons and their splice sites are
highly conserved amongst mammals, and in birds as shown in
Figure 6E.
Rbfox3 sub-cellular localization is not CRM1/exportin
1-dependent
As shown above, Rbfox3v3 exhibits predominantly cytoplasmic
steady-state sub-cellular localization, but is capable of regulating
Rbfox2 alternative splicing to a similar degree as the nuclear-
localized variants Rbfox3v1 and v2. In a preliminary attempt to
determine if Rbfox3v3 actively shuttles between the nucleus and
cytoplasm, we treated N2A cells transiently transfected with
Rbfox3v3 with leptomycin B (LMB) to inhibit CRM1/exportin 1-
dependent nuclear export [26–28]. Figure 7 shows that while the
positive control Rev-GFP was retained in the nucleus after LMB
treatment, no change was seen in the cytoplasmic localization of
Figure 5. Rbfox3 variants all function to regulate alternative splicing, irrespective of steady-state sub-cellular localization. N2A or
293T cells were transiently transfected with Rbfox3 variants 1, 2 or 3 harboring N-terminal flag-tags, or pcDNA3 vector control. A. Alternative splicing
of endogenous mRNAs encoding Rbfox2, c-src and CaV1.2 (alternative exons 9* and 33) was assayed by RT-PCR. Rbfox2 +e6* represents splicing from
exon 5 to a cryptic exon downstream of exon 6. B. Western with anti-flag was used to confirm Rbfox3 overexpression, and anti-actin was used as a
loading control. C. Quantification of the results shown in A and 2 additional experiments (i.e. n=3); results are displayed as average +/2 standard
deviation. All Rbfox3 variants promoted skipping of Rbfox2 exon 6, but no change was seen in the splicing of c-src exon N or CaV1.2 exons 9* or 33
upon Rbfox3 overexpression.
doi:10.1371/journal.pone.0021585.g005
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hPY-NLS, (1) is not capable of entering the cell nucleus or (2) can
enter the nucleus, but is exported via a CRM1-independent
mechanism. Interestingly, although immunofluorescence micros-
copy shows that the steady-state localization of Fox3v3 is
predominantly cytoplasmic, a portion of the protein appears to
be present in the nucleus of HeLa and N2A cells (see Figures 4 &
7); this observation, along with the ability of Fox-3v3 to regulate
Rbfox2 exon 6 skipping, suggests that Fox-3v3 likely does shuttle,
but confirmation of this hypothesis will need further study.
Discussion
The target of the neuronal marker antibody anti-NeuN has
recently been identified as the RNA binding protein Rbfox3 [5].
We have confirmed and extended this finding by IP and MS of
both bands of the NeuN 45–50 kDa doublet. Like NeuN, Rbfox3
mRNA is expressed exclusively in post-mitotic neurons in mouse
brain [5,11], and we have shown that Rbfox3 mRNA is barely
detectable in undifferentiated P19 cells, and strongly upregulated
after retinoic acid-induced neuronal differentiation. Furthermore,
we have demonstrated that Rbfox3 protein isoforms expressed
from transfected cDNA vectors correspond in apparent molecular
weight to the major protein species of NeuN from mouse brain.
Specifically, alternative splicing of exon 12 produces Rbfox3
proteins that differ by approximately 5 kDa, accounting for the
observed anti-NeuN doublet by western; a second alternative
splicing event at the C-terminus of Rbfox3 produces protein
isoforms that differ by 1.4 kDa, likely accounting for the ‘doublet
of doublets’ that can often be resolved with a SDS-PAGE gel (and
subsequent western) of sufficient resolution [1,2]. Proteins with
and without this C-terminal extension have calculated pI values of
,8.1 and 6.8 respectively, so this splicing event also likely accounts
for the separation of both the 45 and 50 kDa bands into two major
anti-NeuN immunoreactive spots after isoelectric focusing and
PAGE observed by Lind et al. [1].
Given Rbfox3 is indeed NeuN, why did we fail to detect it in
our original lambda expression screen? Lind et al. [1] argued that
NeuN is a phosphoprotein, and while not necessarily directly
phosphorylated, the anti-NeuN epitope may be phospho-depen-
Figure 6. Rbfox3 variants enhance inclusion of cryptic exons in Rbfox2, leading to nonsense-mediated decay. N2A cells were
transiently transfected with Rbfox3 variants 1, 2 or 3 harboring N-terminal flag-tags, or pcDNA3 vector control, and treated with emetine to inhibit
NMD. A. Alternative splicing of endogenous mRNAs encoding Ptbp2 and Rbfox2 was assayed by RT-PCR. Enhanced exclusion of Ptbp2 exon 10 was
used as a positive control for emetine treatment. Rbfox2 spliced products are described in D. B. Western with anti-flag was used to confirm Rbfox3
overexpression; anti-actin was used as a loading control. C. Quantification of the results shown in A and 2 additional experiments (i.e. n=3); results
are displayed as average +/2 standard deviation. D. Schematic representation of alternative splicing of the Rbfox2 message around exon 6, indicating
the relative positions of cryptic exons 5* and 6*. The functional outcomes for the resulting spliced mRNA products are depicted below; inclusion of
exon 5* or exon 6* results in the presence of 2 in-frame nonsense codons in exon 7, and destruction of these messages by nonsense-mediated decay.
E. The sequences of mouse Rbfox2 exons 5* and 6* (upper case) and surrounding intronic sequence (lower case) are shown aligned to the
corresponding regions from human and chicken.
doi:10.1371/journal.pone.0021585.g006
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However, we mapped the antibody binding site in Rbfox3 to a 20
amino acid region necessary and sufficient for anti-NeuN binding.
The fact that we achieve recognition in the context of an
autologous protein (GST) implies that the anti-NeuN epitope is
linear, and is unlikely to require a particular structural context for
anti-NeuN recognition. While we cannot rule out the possibility
that the NeuN epitope is directly phosphorylated even when
expressed as a fusion with GST, we believe the most likely
explanation for the failure of the expression screen is that the
epitope in Rbfox3 lies at the extreme N-terminus of the protein.
The lambda screen requires that cloned cDNAs be in-frame with
an N-terminal fragment of b-galactosidase; we speculate that the
cDNA copies of Rbfox3 were either too short to contain the NeuN
epitope, or too long, and thus could contain Rbfox3 59 UTR
sequence, which has a number of in-frame stop codons. However,
our screen did identify a potential anti-NeuN cross-reacting
protein, R3hdm2. We suggest that R3hdm2 may also be a
potential contributor to the anti-NeuN signal in some instances
given that overexpressed R3hdm2 can be detected by anti-NeuN
in immunofluoresencent microscopy (not shown) and by western,
and we observed a series of anti-NeuN immunoreactive bands of
the appropriate size to be R3hdm2 that were specifically
immunoprecipitated with anti-NeuN.
Fox family cross-regulation
In this study, we found that Rbfox3, especially the nuclear splice
variants v1 and v2, in addition to promoting skipping of exon 6 of
Rbfox2, can enhance inclusion of two cryptic exons, which we
have called exon 5* and exon 6*. In both instances, this introduces
a premature stop codon in the Rbfox2 mRNA. Inhibition of the
NMD pathway in mammalian cells resulted in further accumu-
lation of these mRNA species indicating that they are targets of
NMD. A close look at previously published data reveals that
Rbfox1 may also have a similar activity on Rbfox2 [13]. The
outcome of this cryptic splicing in vivo would be to downregulate
Rbfox2 expression in Rbfox3 (and Rbfox1) expressing cells.
Alternative exons that induce NMD have been found to be
particularly frequent in genes encoding splicing regulators [24]. A
number of RNA binding proteins, such as Ptbp1 and SC35
directly influence their own pre-mRNA splicing to introduce
premature termination codons and induce NMD of these mRNA
isoforms, contributing to the maintenance of homeostasis of the
levels of splicing regulators within cells [14,15]. In addition,
paralogous members of splicing regulator families have been
shown to cross-regulate the levels of other family members by a
similar mechanism. For example, hnRNP L enhances the
inclusion of a short cassette exon containing a premature
termination codon in its own message, as well as enhancing the
inclusion of an analogous ‘‘poison’’ exon in closely related hnRNP
L-like [29]. Similarly, Ptbp1 promotes exon skipping in its own,
and closely related Ptbp2 messages, again leading to NMD of the
resulting mRNA isoforms [30,31]. In both of these instances, this
cross-regulation contributes to reciprocal expression of these
proteins in varying cell types.
Fox proteins have been previously shown to auto- and cross-
regulate their production and function by enhancing skipping of a
conserved cassette exon resulting in the expression of dominant
negative DRRM proteins [13]. Here we provide the first evidence
that alternative splicing-associated NMD also regulates Fox family
cross-regulation. The existence of two conserved, complementary
mechanisms for achieving cross- (and auto-) regulation of this
family of RNA binding proteins imply that the absolute levels and
balance of family members must be vitally important to cell
function. Furthermore, our elucidation of the mechanism of
regulation of Rbfox3 sub-cellular distribution suggests that
different neuronal subtypes, which display varying ratios of
nuclear/cytoplasmic anti-NeuN signal, express different Rbfox3
protein variants. In contrast to what has been reported for Rbfox1
[18,32], we found that the cytoplasmic Rbfox3 isoform (v3) did not
have diminished splicing regulatory activity. In fact, we observed
functional differences in the splicing regulation by individual Fox
proteins. Consequently, we predict that different neuronal
subtypes will exhibit differences in the alternative splicing of
target pre-mRNAs regulated by Rbfox3 and its family members,
depending on their exact complement of Fox protein isoforms.
The identification of NeuN as Rbfox3 provides one more
fascinating example of a RNA binding protein that is exquisitely
Figure 7. NeuN (Rbfox3) nuclear export is not Crm1/exportin 1-dependent. Rev-GFP fusion protein or Rbfox3 variant 3 with an N-terminal
flag-tag were expressed in N2A cells and (A) left untreated or (B) treated with 10 ng/ml leptomycin B for 4 hrs prior to fixation and staining with anti-
NeuN and DAPI, or just DAPI in the case of Rev-GFP. Leptomycin B treatment caused Rev-GFP to be retained in the nucleus, but caused no change in
the sub-cellular localization of Fox3v3.
doi:10.1371/journal.pone.0021585.g007
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the Hu family, or neuronally-enriched, such as Ptbp2 (nPTB), and
members of the CELF-Bruno family [33–38]. The recent
development of CLIP, a technique that can specifically identify
in vivo RNA target sites for any particular RNA binding protein,
especially when combined with high-throughput sequencing
methods, can allow one to rapidly move from the identification
of a RNA binding protein to testing specific functional hypotheses
regarding the protein’s biological role in a neuron [39–42].
Indeed, RNA targets of Rbfox2 in embryonic stem cells have
already been identified with such techniques [10]. One interesting
but unanswered question is how do the Rbfox1, Rbfox2 and
Rbfox3 splicing target sets compare? The CLIP technique is
fundamentally dependent on having an antibody able to
specifically IP the protein of interest in complex with bound
RNAs. To that end, we have shown that anti-NeuN robustly and
specifically IPs Rbfox3 (and not Rbfox1 or Rbfox2), and that the
epitope is distant from the RRM, so antibody binding is unlikely to
be occluded by crosslinked RNA. Therefore, a CLIP analysis of
Rbfox3/NeuN should be highly successful.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
Australian code of practice for the care and use of animals for
scientific purposes. The protocol was approved by the University
of Adelaide Animal Ethics Committee (Permit Number: S-033-
2008). Mice were killed by decapitation or carbon dioxide
asphyxiation, and all efforts were made to minimize suffering.
Library screen
We generated a cDNA expression library in Lambda Zap
Express (Stratagene) from poly(A)
+ RNA isolated from P0 mouse
spinal cords with an estimated complexity of 1610
6 independent
clones. The library was screened by probing plaque lifts on
nitrocellulose filters with anti-NeuN mAb at a dilution of 1:500.
Secondary and tertiary screens were used to isolate individual
reactive phage; phagemid rescues were performed according to
protocols from Stratagene, and plasmid DNA containing the
reactive cDNAs were sequenced.
Plasmids
R3hdm2 constructs. The R3hdm2 coding sequence was
amplified by PCR from the largest positive library clone, which
encodes a protein identical to UniProt accession Q80TM6 isoform
3 (Q80TM6-3), and inserted into pET-41a
+ (Novagen) via SpeI
and HindIII to create plasmid FL. DABS is identical to FL except
that it lacks amino acids 543–589 of Q80TM6-3; the deleted
region was replaced with the amino acid sequence ‘‘GT’’ through
creation of an internal KpnI site by PCR. The ABS construct
encodes amino acids 542–587 of Q80TM6-3 fused to the C-
terminus of GST in pET-41a
+. R46-myc was made by PCR
amplification of the GST-ABS fusion from plasmid ABS and
ligation into pCI (Promega) along with linkers to provide a 39 myc-
tag.
Rbfox3 constructs. Rbfox3 coding region was amplified
from mouse brain cDNA by RT-PCR and cloned upstream of a
myc-tag in pCI (Promega) or downstream of a flag-tag in pcDNA3
(Invitrogen). Variant 1 (v1) corresponds to NP_001034256, v2 to
NP_001034257, and v3 to NP_001020102. Fox3D-myc is
identical to Fox3v3-myc except that it lacks amino acids 5–20 of
Fox3v3; the deleted region was replaced with the amino acid
sequence ‘‘GSAP’’ by PCR. F20-myc encodes amino acids 2–21 of
Fox3v3 fused to the C-terminus of GST in pCI; it also contains a
C-terminal myc-tag.
Rev-GFP. HIV-1 Rev positive control for LMB treatment
was plasmid pRev(1.4)-GFP-Rev from [43]. All constructs were
confirmed by sequencing.
Bacterial protein expression
Plasmids were transformed into BL21-CodonPlus (DE3)-RIPL
competent cells (Stratagene), followed by standard IPTG (isopro-
pyl-b-D-thiogalactopyranoside) induction. Bacterial cell pellets
were lysed by boiling in SDS-load buffer prior to analysis by SDS-
PAGE and western.
Immunoprecipitation and mass spectrometry
Mouse brain nuclear extracts were prepared essentially as
described previously [2]. Briefly, fresh brain tissue from C57BL6
mice was minced with a scalpel blade, then homogenized in 0.25%
Triton X-100 in sucrose buffer (0.32 M sucrose, 1 mM MgCl2,
1 mM K-phosphate buffer pH 6.5) with a glass dounce homog-
enizer. Nuclei were pelleted by centrifugation (1,2006g, 10 min)
and washed twice with sucrose buffer; this was considered the
crude nuclear fraction. In some experiments, nuclei were further
purified by resuspending the crude fraction in 2 M sucrose buffer
and centrifuging through a 2.4 M sucrose cushion (53,0006 g,
1 hour).
Nuclei were lysed in whole-cell extract buffer (WCE; 20 mM
HEPES pH 7.5, 420 mM NaCl, 0.5% Igepal, 25% glycerol,
1.5 mM MgCl2) and incubated on ice for 30 min. The lysate was
then diluted 1 in 5 with 20 mM HEPES pH 7.5, supplemented
with 1 mM CaCl2 and treated with 150 units/ml micrococcal
nuclease (Worthington) for 30 min. at 22uC with gentle mixing.
EGTA was added to 2 mM and the lysate clarified by
centrifugation (16,0006 g, 10 mins). EDTA-free complete prote-
ase inhibitors (Roche), 1 mM Na3VO4 and 5 mM NaF were
maintained throughout.
Anti-NeuN antibody, or mouse IgG antibody control was
conjugated to protein-A sepharose beads (GE Healthcare) with
dimethyl pimelimidate (DMP) as described previously [1] except
that antibody binding was performed in the presence of 1 mg/ml
BSA, and the DMP crosslinking incubation was performed twice
prior to quenching the reaction with Tris-HCl pH 7.5. Cross-
linked beads were washed twice with WCE buffer then
resuspended in 750 ml mouse brain nuclear extract and incubated
at 4uC for 1 hour with continuous rotation. The beads were
pelleted by brief centrifugation and the supernatant fraction
collected for analysis. Beads were then washed in WCE buffer
followed by a total of 4 washes alternating between high and low
salt wash buffers (high; 1 M NaCl, 20 mM HEPES pH 7.5, 0.5%
Igepal, low; 16PBS, 0.5% Tween-20). Beads were rinsed briefly
with Na-phosphate buffer pH 7 and eluted with 16Novex LDS
load buffer (Invitrogen) for 10 min at 70uC. Samples were run on
NuPAGE Novex 4–12% bis-tris gels with MES buffer (Invitrogen)
under non-reducing conditions and either transferred to PVDF for
western or stained with SilverQuest staining kit (Invitrogen).
Silver-stained protein bands were excised from the gel and
destained immediately (within 1 hour). Proteins were digested in-
gel with chymotrypsin or trypsin and the extracted peptides were
chromatographed and analyzed using an HCT Ultra 3D-Ion-
Trap mass spectrometer (Bruker Daltonik GmbH). MS and MS/
MS spectra were subjected to peak detection using DataAnalysis
(version 3.4, Bruker Daltonik GmbH) then imported into BioTools
(version 3.1, Bruker Daltonik GmbH). Here, the MS/MS spectra
were submitted to the in-house Mascot database-searching engine
(version 2.2, Matrix Science).
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HeLa, 293T and N2A cells were propagated in DMEM
supplemented with 10% fetal calf serum (FCS). For immunoblots,
cells were transfected in 6-well plates with 0.5–1.0 mg DNA using
Fugene 6 (Roche) for 24 hours. Cells were then washed with
16PBS and lysed in WCE buffer with complete protease inhibitors
(Roche), 1 mM Na3VO4, 5 mM NaF and 0.2 mM EDTA. Lysates
were clarified by centrifugation (16,0006 g, 10 mins) and 15 or
20 mg total protein was boiled in SDS load buffer.
For immunofluorescence, cells were grown on glass coverslips
and transfected for 24 hours prior to fixation or treatment with
10 ng/ml LMB (Enzo Life Sciences) for 4 hours. Cells were fixed
with 4% paraformaldehyde in PBS for 10 min, permeabilized with
0.5% Triton X-100 in PBS for 10 min and blocked with 10% FCS
in PBST (16PBS, 0.1% Triton X-100) for 1 hour. Cells were
incubated with anti-NeuN 1:150 in block for 1 hour, washed 3
times with PBST, then incubated with FITC anti-mouse
secondary antibody (Jackson Immunolabs) 1:200 in block. Cells
were washed 3 times with PBST, with 0.5 mg/ml DAPI included
in the second wash and mounted with ProLong Gold (Invitrogen).
Images were acquired on a Zeiss Axioplan 2 using AxioVision
software.
For target splicing assays, 293T cells and N2A cells were
transfected in 12-well plates with 1.0 mg DNA using Fugene HD
(Roche) for 24 hours prior to harvesting as discussed below.
Emetine treatment was performed by adding 100 mg/ml emetine
to the medium 18 hours after cell transfection, and 10 hours prior
to harvesting.
P19 cells (ATCC) were propagated in a-MEM supplemented
with 10% FCS. For differentiation, 1610
6 cells were transferred to
100 mm bacterial petri dishes in a-MEM supplemented with 5%
FCS and 0.5 mM all-trans retinoic acid (RA, Sigma) for 4 days,
with a medium change at day 2. At day 4, aggregates were treated
with trypsin and DNaseI and plated onto poly-D-lysine coated
tissue culture dishes in a-MEM, 10% FCS without RA and
cultured for a further 3 days.
Western blots
Samples were separated on 12% tris-glycine gels, transferred to
PVDF and immunoblotted using mouse monoclonal anti-GST-tag
1:2000 (Novagen 71097), anti-myc-tag (9B11, Cell Signaling) at
1:1000, anti-HuR (3A2, Santa Cruz) at 1:500, anti-NeuN
(MAB377, Chemicon) at 1:2000 for bacterial samples or 1:500
for eukaryotic samples, anti-flag-tag (Sigma F7425) 1:1000, anti-
actin (Sigma A2066) 1:1000. Detection was performed using
horseradish-peroxidase-conjugated secondary antibodies (Jackson
Immunolabs) and ECL using Western-Lightning-Plus (Perkin
Elmer).
RNA extractions, northern hybridization and RT-PCR
Total RNA was extracted from mouse tissues using a modified
guanidine-acid phenol protocol [44]. Poly(A)
+ RNA was subse-
quently purified using Oligo (dT)25 Dynabeads (Invitrogen)
according to the manufacturer’s instructions. 1–2 mg poly(A)
+
RNA was resolved in a 1% agarose, 2.2 M formaldehyde gel,
transferred to Hybond-N
+ (Amersham), and fixed by UV-cross-
linking. Northern hybridization was performed in Ultrahyb
(Ambion) at 68uC. Antisense RNA probes were transcribed using
Ambion’s Strip-EZ RNA T7 kit, and labeled by incorporation of
[a-
32P]-UTP. The R3hdm2 probe template was amplified by PCR
using primers F:gaacgaattcCGAGTGGCTAAAAAGAACTAC-
GACC and R:agaaccaagcttAAATGGGAAAAGGGGAGGG-
CAG, cloned into pcDNA3 via the HindIII and EcoRI sites, and
linearized with EcoRI. The b-actin probe was transcribed from
plasmid pTRI-b-Actin-Mouse (Ambion). The blot was visualized
by Typhoon PhosphorImager and quantified using ImageQuant.
Total RNA was purified from tissue culture cells using the
RNeasy Mini kit system (Qiagen). Total RNA was reverse
transcribed using random hexamers and SuperScript III (Invitro-
gen). Rbfox3 and gapdh products were amplified (28 cycles) using
Taq polymerase (Invitrogen) and visualized in agarose gels with
ethidium bromide. The primers were as follows: Rbfox3 e7-F,
TTTAACGAGCGGGGCTCCAAG; e15A-R, TTCATGGTC-
CGAGAAGGAGACG; e15-R, GGTCTCTTGCTAGTAGGG-
GGTGAAG; e14-R, CATGGTTCCGATGCTGTAGG; Gapdh
F, CGTCCCGTAGACAAAATGGT; R, CACATTGGGGG-
TAGGAACACG.
Endogenous splicing targets were amplified for 22 cycles
(Rbfox2, Ptbp2), or 25 cycles (c-src and CaV1.2) using Taq
polymerase (Invitrogen) and FAM-labeled 39 or 59 primers.
Products were separated on 6% native polyacrylamide-TBE gels,
visualized using a Typhoon Trio scanner and quantified using
NIH ImageJ. Primers for Rbfox2, mouse c-src and CaV1.2 were
as published [13,45,22]. For human c-src the 59 primer used was
CTGTCCTTCAAGAAAGGCGAGC (1 nt change from the
mouse primer). Primers for Ptbp2 were F, CTGGTGGCAATA-
CAGTCCTGTTG; R, TGGTTCCCATCAGCCATCTG. All
PCR products were confirmed by gel extraction and sequencing.
Supporting Information
Figure S1 All myc-tagged and flag-tagged Rbfox3 vari-
ants function to regulate alternative splicing, irrespec-
tive of steady-state sub-cellular localization. 293T cells
were transiently transfected with increasing amounts of Rbfox3
variants 1, 2 or 3 harboring N-terminal flag-tags, or C-terminal
myc-tags in 12-well plates. Empty vector was also added such that
each well received 2 mg of plasmid. A. Upper panel: alternative
splicing of endogenous Rbfox2 mRNA was assayed by RT-PCR.
Lower panel: equal amounts of protein extract were separated by
SDS-PAGE and immunoblotted with anti-NeuN and FITC-
conjugated secondary antibody. The blots were visualized using a
Typhoon Trio scanner and quantified using NIH ImageJ. The two
gels were run back-to-back and processed together to enable
quantification of the relative NeuN amounts; lane 1 was set to 1
and subsequent lanes are displayed as the fold-change from this
value. Numbers in bold italics correspond to the samples used for
quantification in B. B.Quantification of the RT-PCR results
shown in A in bold. Only samples with similar levels of NeuN
protein (2 to 3-fold above the amount in the first lane) are graphed,
along with the controls. All Rbfox3 variants, whether flag- or myc-
tagged, promoted skipping of Rbfox2 exon 6 to a similar degree.
However, the inclusion of cryptic exon e6* was markedly higher
after transfection of Rbfox3 protein variants which display nuclear
steady-state subcellular distribution (namely flag-Fox3v1 and v2).
(TIF)
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